Related Experiment Video
Updated: Feb 10, 2026

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013
Osteochondral Angiogenesis and Promoted Vascularization: New Therapeutic Target
1Institute of Polymer Science and Technology, Spanish National Research Council (ICTP-CSIC), Madrid, Spain. luis.garcia@csic.es.
Abstract:
The control of the different angiogenic process is an important point in osteochondral regeneration. Angiogenesis is a prerequisite for osteogenesis in vivo; insufficient neovascularization of bone constructs after scaffold implantation resulted in hypoxia and cellular necrosis. Otherwise, angiogenesis must be avoided in chondrogenesis; vascularization of the cartilage contributes to structural damage and pain. Finding a balance between these processes is important to design a successful treatment for osteochondral regeneration. This chapter shows the most important advances in the control of angiogenic process for the treatment of osteochondral diseases focused on the administration of pro- or anti-angiogenic factor and the design of the scaffold.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Mechanism of Angiogenesis
Seedless Vascular Plants
Therapeutic Index
Regulation of Angiogenesis and Blood Supply

